Answers are grounded in this paper and cite their sources.
Interpretation of abnormal D-dimer (DD) results in psychiatric inpatients is complicated by age, somatic comorbidity, multidomain laboratory abnormalities, and psychotropic medication treatment. This study examined demographic, laboratory, and active psychotropic medication-order contexts associated with abnormal DD results to support more context-specific DD interpretation in psychiatric inpatient care. This single-center retrospective observational study included psychiatric inpatients undergoing routine admission DD screening from August 2018 to October 2019. The first DD result from each hospital admission was used for the primary analysis. DD was modeled as log-transformed levels, binary elevation (>0.55 mg/L fibrinogen equivalent units [FEU]), and a four-level severity outcome. Twenty-four laboratory indicators measured on the date of DD testing across five clinical domains were screened in single-indicator models, and 12 representative indicators were included in an age-, sex-, and diagnosis-adjusted integrated model. Psychotropic medication exposure, operationalized as active medication orders on the DD sampling date, was analyzed by drug class, individual medication, prescribed daily dose, and therapeutic drug monitoring (TDM) concentration, with supplementary repeated-measures generalized estimating equations (GEE) analyses accounting for within-patient correlation. Sensitivity analyses tested alternative handling of low DD values, exclusion of severe DD elevation, age stratification, and analyses including all DD records. Among 10211 hospital admissions contributed by 9320 patients, 2100 (20.57%) had elevated DD. Each 10-year age increase was associated with DD elevation (odds ratio [OR] 1.494, 95% confidence interval [CI] 1.450–1.541) and higher logDD (geometric mean ratio [GMR] 1.213, 95% CI 1.199–1.227). In the integrated model of 6507 records, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), lactate dehydrogenase (LDH), and prolactin (PRL) were consistently associated with higher DD across outcome definitions, whereas activated partial thromboplastin time (APTT) and triglycerides (TG) were associated with lower DD. LDH, APTT, and PRL showed the greatest robustness across sensitivity analyses. Lithium and valproate exposure were associated with lower DD, whereas olanzapine exposure was associated with higher DD, although these associations were not accompanied by stable dose-response or concentration-response patterns. DD elevation was common in psychiatric inpatients and reflected a multidimensional clinical context involving clinical characteristics, laboratory abnormalities, and order-based psychotropic medication-related factors, rather than an isolated thrombotic marker or a simple direct medication effect. Integrating venous thromboembolism (VTE) risk assessment, DD severity, concurrent laboratory findings, and individual psychotropic medication information may help clinicians identify conditions requiring further evaluation and support more targeted physical health assessment during psychiatric hospitalization and rehabilitation. Not applicable. This was a retrospective observational study using historical clinical data and did not involve prospective assignment of participants to an intervention.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: